Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
#2PRI RANKED
Most Cited Paper
in Virus-based gene therapy research
18 Months Post-Publication
Class of 2026
“Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026/
Topics
CAR T-cell therapy · Secondary malignancies · T-cell lymphoma · Vector Genome Integration · Adoptive cell therapy · retroviral integration · clonal hematopoiesis · oncogenic integration · viral vector monitoring · clonal relationships · T-cell neoplasms · Secondary malignancies
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026. https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459